Core Scientific, Inc. Tranche 2 Warrants
Core Scientific, Inc. provides digital asset mining services in the United States. It operates through three segments: Digital Asset Self-Mining; Digital Asset Hosted Mining; and HPC Hosting. The company offers digital infrastructure, software solutions, and services; and operates licensing data center space facilities. It also deploys and operates own large fleet of miners within owned digital i… Read more
Core Scientific, Inc. Tranche 2 Warrants (CORZZ) - Net Assets
Latest net assets as of September 2025: $-1.13 Billion USD
Based on the latest financial reports, Core Scientific, Inc. Tranche 2 Warrants (CORZZ) has net assets worth $-1.13 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.30 Billion) and total liabilities ($3.42 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.13 Billion |
| % of Total Assets | -49.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | -713.45% |
| 10-Year Change | N/A |
| Growth Volatility | 459.91 |
Core Scientific, Inc. Tranche 2 Warrants - Net Assets Trend (2019–2024)
This chart illustrates how Core Scientific, Inc. Tranche 2 Warrants's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Core Scientific, Inc. Tranche 2 Warrants (2019–2024)
The table below shows the annual net assets of Core Scientific, Inc. Tranche 2 Warrants from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | $-820.18 Million | -37.40% |
| 2023-09-30 | $-596.94 Million | -45.83% |
| 2022-09-30 | $-409.35 Million | -130.52% |
| 2021-09-30 | $1.34 Billion | +903.15% |
| 2020-09-30 | $133.70 Million | -1.59% |
| 2019-09-30 | $135.85 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Core Scientific, Inc. Tranche 2 Warrants's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 367268000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.00K | % |
| Other Components | $2.92 Billion | % |
| Total Equity | $-820.18 Million | 100.00% |
Core Scientific, Inc. Tranche 2 Warrants Competitors by Market Cap
The table below lists competitors of Core Scientific, Inc. Tranche 2 Warrants ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Salubris Pharmaceuticals Co Ltd
SHE:002294
|
$3.52 Billion |
|
Amorepacific Corp. (New)
KO:090430
|
$3.52 Billion |
|
Davide Campari-Milano N.V
PINK:DVDCF
|
$3.52 Billion |
|
PETRONAS Gas Berhad
PINK:PNAGF
|
$3.52 Billion |
|
Kadant Inc
NYSE:KAI
|
$3.51 Billion |
|
Franklin Electric Co Inc
NASDAQ:FELE
|
$3.51 Billion |
|
KION GROUP AG
OTCGREY:KNNGF
|
$3.51 Billion |
|
Lagercrantz Group AB (publ)
ST:LAGR-B
|
$3.51 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Core Scientific, Inc. Tranche 2 Warrants's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -596,941,000 to -820,180,000, a change of -223,239,000.
- Net loss of 1,315,005,000 reduced equity.
- New share issuances of 55,000,000 increased equity.
- Other factors increased equity by 1,036,766,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.32 Billion | -160.33% |
| Share Issuances | $55.00 Million | +6.71% |
| Other Changes | $1.04 Billion | +126.41% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Core Scientific, Inc. Tranche 2 Warrants's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-09-30 | $3.15 | $16.52 | x |
| 2020-09-30 | $3.10 | $16.52 | x |
| 2021-09-30 | $5.75 | $16.52 | x |
| 2022-09-30 | $-1.09 | $16.52 | x |
| 2023-09-30 | $-1.57 | $16.52 | x |
| 2024-09-30 | $-3.21 | $16.52 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Core Scientific, Inc. Tranche 2 Warrants utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -257.50%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-2.40%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -8.78% | -20.03% | 0.37x | 1.19x | $-25.51 Million |
| 2020 | -9.13% | -20.24% | 0.27x | 1.69x | $-25.58 Million |
| 2021 | 3.53% | 8.69% | 0.22x | 1.82x | $-86.81 Million |
| 2022 | 0.00% | -335.20% | 0.79x | 0.00x | $-2.11 Billion |
| 2023 | 0.00% | -49.06% | 0.71x | 0.00x | $-186.79 Million |
| 2024 | 0.00% | -257.50% | 0.32x | 0.00x | $-1.23 Billion |
Industry Comparison
This section compares Core Scientific, Inc. Tranche 2 Warrants's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Core Scientific, Inc. Tranche 2 Warrants (CORZZ) | $-1.13 Billion | -8.78% | N/A | $3.51 Billion |
| Abcam plc (ABCZF) | $726.90 Million | -1.17% | 0.45x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |
| Alvotech Warrant (ALVOW) | $-564.42 Million | 0.00% | 0.00x | $35.01 Million |